In-Depth Examination of Segments, Industry Developments, and Key Players in the Edible Vaccine Market

The edible vaccine market is emerging as a promising segment within the pharmaceutical and biotechnology industries, driven by innovative approaches to vaccination that avoid traditional needles. As the demand for safer, more accessible immunization methods rises, this sector is set to witness substantial expansion. Let's explore the market's projected growth, key players, prevailing trends, and segment breakdowns shaping its future.

Projected Market Value and Growth Trajectory of the Edible Vaccine Market
The edible vaccine market is anticipated to grow significantly in the coming years, reaching a valuation of $14.54 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 8.9%. Key factors propelling this growth include increasing preference for needle-free vaccine delivery, heightened investments in clinical trials focusing on edible vaccines, expansion of immunization programs for livestock, enhanced global efforts to improve vaccine accessibility, and advancements in regulatory approval processes. Important trends expected to influence this market encompass innovations in plant-based vaccine expression systems, a rising interest in oral vaccine delivery methods, development of cost-effective vaccine production models, research into heat-stable vaccines, and growing collaborations between the biotechnology and agricultural sectors.

Download a free sample of the edible vaccine market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19040&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Feb_PR

Leading Companies Influencing the Edible Vaccine Market Landscape
Several prominent organizations dominate the edible vaccine market, playing critical roles in development and commercialization. These major players include Medicago Inc., Vaxart Inc., Vaxiion Therapeutics Inc., Mymetics Corporation, Profectus BioSciences Inc., GreenLight Biosciences Inc., Akston Biosciences Corporation, Icon Genetics GmbH, iBio Inc., Kentucky BioProcessing Inc., Fraunhofer USA Center for Molecular Biotechnology, Nomad Bioscience GmbH, Baiya Phytopharm Company Limited, Dow AgroSciences LLC, GenCure Biomanufacturing, Transgene SA, PlantForm Corporation, BioBetter Ltd., Moolec Science SA, and Agrenvec SL.

Recent Market Activity and Strategic Acquisitions
In June 2024, Lee Aerospace, a US-based aerospace company, acquired Llamas Plastics Inc., a manufacturer specializing in aerospace plastics, for an undisclosed sum. This acquisition aims to provide Lee Aerospace with direct access to the military and aerospace sectors, diversify its product portfolio, and enhance its production capabilities, marking a strategic expansion move within relevant markets.

View the full edible vaccine market report:
https://www.thebusinessresearchcompany.com/report/edible-vaccine-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Feb_PR

Innovative Solutions and Opportunities Emerging in the Edible Vaccine Sector
Key companies in the edible vaccine market are prioritizing the development of novel vaccines to address pressing health challenges, such as the global cholera crisis. For example, oral cholera vaccines (OCVs) offer a needle-free method to prevent cholera, which is caused by the bacterium Vibrio cholerae. In August 2024, India-based Bharat Biotech International Limited introduced Hillchol, an oral cholera vaccine featuring a live-attenuated formulation that stimulates both systemic and mucosal immunity. Hillchol's ease of administration, lack of cold storage requirements, and single-dose long-lasting immunity make it particularly suitable for resource-constrained environments.

Market Segmentation Highlighting the Largest Edible Vaccine Market Share
This report categorizes the edible vaccine market into several segments to provide a detailed overview:

1) Vaccine Type: including Subunit Vaccines, Virus-Like Particle (VLP) Vaccines, Plant-Expressed Antigen Vaccines, Recombinant Protein Vaccines, and Other Types of Edible Vaccines
2) Source: encompassing Fruits, Vegetables, Cereal Grains, Legumes, and Other Edible Plants
3) Route of Administration: such as Oral Fresh Plant Consumption, Oral Processed Edible Form Feed, and Sublingual and Buccal Edible Extract-Based methods
4) Distribution Model: including Public Health and Immunization Programs, Veterinary and Animal Health Programs, Direct Farm-Level Administration, and Research and Academic Institutions
5) Application: covering Human Immunization, Veterinary Vaccines, Livestock, Poultry, Aquaculture Vaccines, and Other Areas
6) End User: segmented into Adults, Pediatrics, and Animals

Further Subcategories within the segments include:
- Subunit Vaccines divided into Protein Subunit Vaccines, Polysaccharide Subunit Vaccines, and Conjugated Subunit Vaccines
- VLP Vaccines classified as Plant-Derived VLP Vaccines, Chimeric VLP Vaccines, and Multi-Antigen VLP Vaccines
- Plant-Expressed Antigen Vaccines categorized by Fruit-Based, Vegetable-Based, Grain-Based, and Legume-Based types
- Recombinant Protein Vaccines split into Recombinant Bacterial Antigen Vaccines, Recombinant Viral Antigen Vaccines, and Recombinant Parasitic Antigen Vaccines
- Other Edible Vaccine Types including Oral Mucosal Immunity-Targeted Vaccines, Multi-Epitope Edible Vaccines, and Combination Edible Vaccines

This detailed segmentation enables a comprehensive understanding of the edible vaccine market's structure and growth opportunities as it evolves in the coming years.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.